AR076205A1 - Derivados de 1-alquil-cinolin-4(1h)-ona, su preparacion, composicion farmaceutica y su uso para tratar patologias en la que esten implicados receptores de cannabinoides cb2 - Google Patents
Derivados de 1-alquil-cinolin-4(1h)-ona, su preparacion, composicion farmaceutica y su uso para tratar patologias en la que esten implicados receptores de cannabinoides cb2Info
- Publication number
- AR076205A1 AR076205A1 ARP100101135A ARP100101135A AR076205A1 AR 076205 A1 AR076205 A1 AR 076205A1 AR P100101135 A ARP100101135 A AR P100101135A AR P100101135 A ARP100101135 A AR P100101135A AR 076205 A1 AR076205 A1 AR 076205A1
- Authority
- AR
- Argentina
- Prior art keywords
- alk
- group
- several times
- halogen atom
- substituted once
- Prior art date
Links
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 abstract 7
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 abstract 1
- -1 1-benzothienyl Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 1: Compuesto que responde a la formula (1) en la que X representa un radical bivalente alquileno C2-5 no sustituido o sustituido una o varias veces con un grupo Alk; R1 representa un fenilo sustituido una o varias veces con sustituyentes elegidos independientemente entre un átomo de halogeno, un grupo Alk, un grupo OAlk, un ciano, un grupo -NHSO2Alk; un naftilo no sustituido o sustituido una o varias veces con sustituyentes elegidos independientemente entre un átomo de halogeno, un grupo Alk, un grupo OAlk; un piridilo no sustituido o sustituido una o varias veces con sustituyentes elegidos independientemente entre un átomo de halogeno, un grupo Alk, un grupo OAlk; un 1-benzotienilo no sustituido o sustituido una o varias veces con sustituyentes elegidos independientemente entre un átomo de halogeno, un grupo Alk, un grupo OAlk; un 1,3-benzodioxolilo no sustituido o sustituido una o varias veces con sustituyentes elegidos independientemente entre un átomo de halogeno, un grupo Alk, un grupo OAlk; R2 representa un átomo de hidrogeno, un átomo de halogeno, un grupo Alk, un grupo OAlk o bien un grupo elegido entre -S-Alk, -SO-Alk, -SO2-Alk, -CON(R4)-Alk, -N(R4)SO2-Alk, -N(R4)CO-Alk, -N(R4)SO2-N(Alk)2; R3 representa un átomo de hidrogeno, un átomo de halogeno, un grupo Alk o un grupo OAlk; R4 representa un átomo de hidrogeno o un alquilo C1-4; Alk representa un alquilo C1-4 no sustituido o sustituido una o varias veces con un átomo de fluor; en el estado de base o de sal de adicion a un ácido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901696A FR2944013B1 (fr) | 2009-04-07 | 2009-04-07 | Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR076205A1 true AR076205A1 (es) | 2011-05-26 |
Family
ID=41051781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100101135A AR076205A1 (es) | 2009-04-07 | 2010-04-06 | Derivados de 1-alquil-cinolin-4(1h)-ona, su preparacion, composicion farmaceutica y su uso para tratar patologias en la que esten implicados receptores de cannabinoides cb2 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8420651B2 (es) |
| EP (1) | EP2417111B1 (es) |
| JP (1) | JP5651683B2 (es) |
| KR (1) | KR20120027212A (es) |
| CN (1) | CN102459195A (es) |
| AR (1) | AR076205A1 (es) |
| AU (1) | AU2010233590A1 (es) |
| BR (1) | BRPI1015951A2 (es) |
| CA (1) | CA2757859A1 (es) |
| CL (1) | CL2011002500A1 (es) |
| CO (1) | CO6440578A2 (es) |
| EA (1) | EA201171212A1 (es) |
| FR (1) | FR2944013B1 (es) |
| IL (1) | IL215512A0 (es) |
| MA (1) | MA33250B1 (es) |
| MX (1) | MX2011010650A (es) |
| SG (1) | SG175128A1 (es) |
| TW (1) | TW201040147A (es) |
| UY (1) | UY32548A (es) |
| WO (1) | WO2010116084A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY39214A (es) * | 2020-05-19 | 2021-12-31 | Syngenta Crop Protection Ag | Compuestos herbicidas sustituídos con azufre |
| BR112022023550A2 (pt) | 2020-05-19 | 2023-01-03 | Bayer Cropscience Ag | (tio)amidas azabicíclicas como compostos fungicidas |
| WO2021249995A1 (en) | 2020-06-10 | 2021-12-16 | Bayer Aktiengesellschaft | Azabicyclyl-substituted heterocycles as fungicides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200306839A (en) * | 2002-02-06 | 2003-12-01 | Novartis Ag | Quinazolinone derivatives and their use as CB agonists |
| WO2009053799A1 (en) | 2007-10-24 | 2009-04-30 | Glenmark Pharmaceuticals, S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| FR2933697B1 (fr) * | 2008-07-11 | 2010-08-13 | Sanofi Aventis | Derives de 1-benzyl-cinnolin-4-(1h)-one substitues, leur preparation et leur application en therapeutique |
-
2009
- 2009-04-07 FR FR0901696A patent/FR2944013B1/fr active Active
-
2010
- 2010-04-06 MX MX2011010650A patent/MX2011010650A/es unknown
- 2010-04-06 BR BRPI1015951A patent/BRPI1015951A2/pt not_active Application Discontinuation
- 2010-04-06 CN CN2010800251635A patent/CN102459195A/zh active Pending
- 2010-04-06 AU AU2010233590A patent/AU2010233590A1/en not_active Abandoned
- 2010-04-06 US US13/262,869 patent/US8420651B2/en not_active Expired - Fee Related
- 2010-04-06 JP JP2012504054A patent/JP5651683B2/ja not_active Expired - Fee Related
- 2010-04-06 CA CA2757859A patent/CA2757859A1/fr not_active Abandoned
- 2010-04-06 EA EA201171212A patent/EA201171212A1/ru unknown
- 2010-04-06 TW TW099110626A patent/TW201040147A/zh unknown
- 2010-04-06 EP EP10723208.4A patent/EP2417111B1/fr active Active
- 2010-04-06 MA MA34318A patent/MA33250B1/fr unknown
- 2010-04-06 SG SG2011073426A patent/SG175128A1/en unknown
- 2010-04-06 KR KR1020117026302A patent/KR20120027212A/ko not_active Withdrawn
- 2010-04-06 AR ARP100101135A patent/AR076205A1/es unknown
- 2010-04-06 WO PCT/FR2010/050657 patent/WO2010116084A1/fr not_active Ceased
- 2010-04-07 UY UY0001032548A patent/UY32548A/es not_active Application Discontinuation
-
2011
- 2011-10-03 IL IL215512A patent/IL215512A0/en unknown
- 2011-10-07 CL CL2011002500A patent/CL2011002500A1/es unknown
- 2011-10-07 CO CO11132791A patent/CO6440578A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2944013B1 (fr) | 2011-07-15 |
| CN102459195A (zh) | 2012-05-16 |
| CA2757859A1 (fr) | 2010-10-14 |
| UY32548A (es) | 2010-11-30 |
| AU2010233590A1 (en) | 2011-11-03 |
| MX2011010650A (es) | 2012-01-20 |
| US20120129864A1 (en) | 2012-05-24 |
| KR20120027212A (ko) | 2012-03-21 |
| MA33250B1 (fr) | 2012-05-02 |
| WO2010116084A1 (fr) | 2010-10-14 |
| JP2012522829A (ja) | 2012-09-27 |
| SG175128A1 (en) | 2011-11-28 |
| US8420651B2 (en) | 2013-04-16 |
| CL2011002500A1 (es) | 2012-03-23 |
| IL215512A0 (en) | 2011-12-29 |
| CO6440578A2 (es) | 2012-05-15 |
| EP2417111B1 (fr) | 2014-06-04 |
| TW201040147A (en) | 2010-11-16 |
| BRPI1015951A2 (pt) | 2016-04-26 |
| EP2417111A1 (fr) | 2012-02-15 |
| EA201171212A1 (ru) | 2012-04-30 |
| JP5651683B2 (ja) | 2015-01-14 |
| FR2944013A1 (fr) | 2010-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
| EA200602058A1 (ru) | Производные адамантилпирролидин-2-она в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
| GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| EA200901609A1 (ru) | Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов | |
| UY31260A1 (es) | Compuestos de pirazol, composiciones conteniendolos y aplicaciones. | |
| AR062292A1 (es) | Derivados de pirrolo (2,3 d) pirimidina como inhibidor de pi3k, composiciones farmaceuticas y usos de los mismos | |
| BRPI0814065B8 (pt) | derivados de alcoóis de 1-fenil-2-piridinil alquila como inibidores da fosfodiesterase | |
| CO6362007A2 (es) | Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparación y su aplicación en terapeútica | |
| EA201100875A1 (ru) | Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов | |
| CR20140045A (es) | Compuestos de n-tio-antranilamida y sus usos como plaguicidas | |
| EA201100877A1 (ru) | Спирогетероциклические n-оксиамиды в качестве пестицидов | |
| CY1112102T1 (el) | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| EA200901124A1 (ru) | Соединения формулы (i) в качестве ингибиторов серинпротеазы | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| EA201101334A1 (ru) | Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их | |
| UY30897A1 (es) | Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones | |
| CO6351789A2 (es) | Derivados de carbamatos de alquiltiazoles, su preparacion y su aplicacion en terapeutica | |
| DOP2006000045A (es) | Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica | |
| UY27852A1 (es) | Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| DK1899325T3 (da) | Imidazolinon- og hydantoinderivater som hidtil ukendte hæmmere af histondeacetylase | |
| BR112015024109A2 (pt) | derivados de ureia e seu uso como inibidores de proteína de ligação de ácidos graxos (fabp) | |
| CR8205A (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| AR076205A1 (es) | Derivados de 1-alquil-cinolin-4(1h)-ona, su preparacion, composicion farmaceutica y su uso para tratar patologias en la que esten implicados receptores de cannabinoides cb2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |